調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021

局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021）

◆タイトル：Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021
◆商品コード：MAM-MD-5119
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年3月27日
◆ページ数：145
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥615,850	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥724,850	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥888,350	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、局所ドラッグデリバリ（局所薬物送達）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品種類別分析、需要先別分析、地域別分析、局所ドラッグデリバリ（局所薬物送達）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes.
The market is segmented based on product type, route of administration, facility of use, and regions. On the basis of product type, the market is segmented into formulations and devices (transdermal drug delivery). Transdermal drug delivery is expected to offer lucrative growth opportunities and represents a new revenue pocket for market players. This is because transdermal drug delivery offers enhanced therapeutic efficiency and helps maintain a steady plasma level of the drug.

On the basis of route of administration, the market is segmented into skin, ophthalmic, rectal, vaginal, and nasal routes. Considering the high incidence of skin diseases, high demand for self-administration, and the increasing number of product approvals for skin-related drug delivery systems, the market for topical drugs administered through the skin is expected to register the highest CAGR during the forecast period.

Based on facility of use, the topical drug delivery market is categorized into hospitals and private clinics, health care settings, and other facilities of use such as research institutes and diagnostic centers. The hospitals and private clinics segment is expected to be the major end-user in the market. This large share of this segment can is mainly attributed to the increasing incidence of skin diseases, the subsequent increase in the demand for topical products for the treatment of these diseases, increase in funding, and infrastructural development in hospitals.

Based on region, North America dominates the market, followed by Europe. However, the market in the Asia-Pacific is expected to witness the highest growth during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries.

Key players operating in the global topical drug delivery market are Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India).

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Topical Drug Delivery Market, By Route of Administration
4.2 Topical Drug Delivery Market, By Product Type
4.3 Geographic Snapshot of the Topical Drug Delivery Market

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 High Prevalence of Skin Diseases
5.3.2 Growing Preference for Topical Drug Delivery
5.3.3 High Incidence of Burn Injuries
5.3.4 Rising Incidence of Diabetes
5.3.5 Rising Geriatric Population
5.4 Restraints
5.4.1 Negative Impact of Product Recalls
5.5 Opportunities
5.5.1 Delivery of Biologics Through the Transdermal Route
5.5.2 Acquisition of Small Market Players
5.6 Challenges
5.6.1 Limited Therapeutic Areas of Topical Drug Delivery

6 Topical Drug Delivery Market, By Product Type (Page No. – 38)
6.1 Introduction
6.1.1 Formulations
6.1.1.1 Liquid Topical Formulations
6.1.1.1.1 Solutions
6.1.1.1.2 Suspensions
6.1.1.2 Semi-Solid Topical Formulations
6.1.1.2.1 Creams
6.1.1.2.2 Gels
6.1.1.2.3 Ointments
6.1.1.2.4 Pastes
6.1.1.2.5 Lotions
6.1.1.3 Solid Topical Formulations
6.1.1.3.1 Suppositories
6.1.1.3.2 Powders
6.1.2 Devices (Transdermal Drug Delivery)
6.1.2.1 Transdermal Patches
6.1.2.2 Transdermal Gels

7 Topical Drug Delivery Market, By Route of Administration (Page No. – 53)
7.1 Introduction
7.2 Skin Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery

8 Topical Drug Delivery Market, By Facility of Use (Page No. – 62)
8.1 Introduction
8.2 Hospitals and Private Clinics
8.3 Home Care Settings
8.4 Other Facilities of Use

9 Topical Drug Delivery Market, By Region (Page No. – 67)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of APAC
9.5 Rest of the World

10 Competitive Landscape (Page No. – 99)
10.1 Overview
10.2 Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements & Collaborations
10.3.4 Expansions

11 Company Profiles (Page No. – 106)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Glaxosmithkline PLC
11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.3 Novartis AG
11.4 Galderma S.A.
11.5 Valeant Pharmaceuticals International, Inc.
11.6 Bayer AG
11.7 3M Drug Delivery Systems
11.8 Crescita Therapeutics Inc.
11.9 Medpharm
11.10 Cipla

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 138)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Available Customizations
12.5 RT: Real-Time Market Intelligence
12.6 Related Reports
12.7 Author Details

List of Tables (87 Tables)

Table 1 Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 2 Topical Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 3 Topical Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 4 Liquid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 5 Liquid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 6 Topical Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 7 Topical Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 8 Semi-Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 9 Semi-Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Topical Creams Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Topical Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 12 Topical Ointments Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Topical Pastes Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Topical Lotions Market Size, By Region, 2014–2021 (USD Billion)
Table 15 Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 16 Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Topical Suppositories Market Size, By Region, 2014–2021 (USD Billion)
Table 18 Topical Powders Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Transdermal Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 20 Transdermal Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 21 Transdermal Patches Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Transdermal Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Topical Drug Delivery Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 24 Commercially Available Products
Table 25 Skin Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Commercially Available Products
Table 27 Ophthalmic Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 28 Rectal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 29 Vaginal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 30 Commercially Available Products
Table 31 Nasal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 32 Global Topical Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 33 Topical Drug Delivery Market Size for Hospitals and Private Clinics, By Region, 2014–2021 (USD Billion)
Table 34 Topical Drug Delivery Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 35 Topical Drug Delivery Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 36 Topical Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 37 North America: Market Size, By Country, 2014-2021 (USD Billion)
Table 38 North America: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 39 North America: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 40 North America: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 41 U.S.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 42 U.S.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 43 U.S.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 44 Canada: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 45 Canada: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 46 Canada: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Billion)
Table 48 Europe: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 49 Europe: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 50 Europe: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 51 Germany: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 52 Germany: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 53 Germany: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 54 France: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 55 France: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 56 France: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 57 U.K.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 58 U.K.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 59 U.K.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 60 RoE: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 61 RoE: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 62 RoE: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 63 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Billion)
Table 64 APAC: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 65 APAC: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 66 APAC: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 67 Japan.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 68 Japan: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 69 Japan: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 70 China.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 71 China: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 72 China: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 73 India: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 74 India: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 75 India: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 76 Rest of APAC: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 77 Rest of APAC: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 78 Rest of APAC: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 79 RoW: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 80 RoW: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 81 RoW: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 82 Market, By Key Player, 2015
Table 83 Product Launches & Approvals, 2013–2017
Table 84 Acquisitions, 2013–2017
Table 85 Agreements & Collaborations, 2013–2017
Table 86 Expansions, 2013–2017
Table 87 Exchange Rate (Utilized for Conversion of Inr to USD)

List of Figures (41 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Formulations Segment to Dominate the Global Topical Drug Delivery Market, By Product, During the Forecast Period
Figure 9 Hospitals and Private Clinics to Hold Largest Share of the Market, By Facility of Use, During the Forecast Period
Figure 10 Skin Drug Delivery Segment to Dominate the Topical Drug Delivery Market, By Route of Administration
Figure 11 North America Expected to Hold the Largest Market Share in 2016, Asia-Pacific to Witness Highest Growth
Figure 12 Topical Drug Delivery Market Overview Increasing Prevalence of Skin Diseases, the Key Growth Driver of Market Growth
Figure 13 Formulations Segment to Dominate the Topical Drug Delivery Market, By Product
Figure 14 Skin to Command the Largest Share of the Route of Administration Market in 2016
Figure 15 Semi-Solid Formulations Segment to Grow at the Highest CAGR in the Topical Drug Delivery Formulations Market
Figure 16 Hospitals and Private Clinics Segment to Witness Highest Growth in the Forecast Period
Figure 17 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 18 Topical Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Formulations to Command the Largest Share of the Topical Drug Delivery Market in 2016
Figure 20 Transdermal Drug Delivery to Dominate the Market During the Forecast Period
Figure 21 Asia-Pacific to Register Highest Growth in the Skin Drug Delivery Market
Figure 22 Hospitals and Private Clinics Segment to Command the Largest Share of the Topical Drug Delivery Market in 2016
Figure 23 APAC Hospitals and Private Clinics Market to Witness Highest Growth (2016 - 2021)
Figure 24 North America: Topical Drug Delivery Market Snapshot
Figure 25 Europe: Topical Drug Delivery Market Snapshot
Figure 26 APAC: Topical Drug Delivery Market Snapshot
Figure 27 RoW: Topical Drug Delivery Market Snapshot
Figure 28 Key Developments in the Topical Drug Delivery Market, 2013–2017
Figure 29 Market Evolution Framework
Figure 30 Battle for Market Share: Product Launches and Approvals Accounted for the Largest Share
Figure 31 Geographic Revenue Mix of the Top 5 Players in the Topical Drug Delivery Market
Figure 32 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 33 Johnson & Johnson: Company Snapshot (2015)
Figure 34 Novartis AG: Company Snapshot (2015)
Figure 35 Nestlé S.A.: Company Snapshot (2015)
Figure 36 Valeant Pharmaceuticals International, Inc.: Company Snapshot (2015)
Figure 37 Bayer Ag.: Company Snapshot (2015)
Figure 38 Exchange Rate (Utilized for the Conversion of EUR to USD)
Figure 39 3M: Company Snapshot (2015)
Figure 40 Nuvo Research: Company Snapshot (2015)
Figure 41 Cipla: Company Snapshot (2015)

【レポートのキーワード】

局所ドラッグデリバリ、局所薬物送達、薬剤、医薬品、経皮パッチ

★調査レポート[局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021）] ( Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 / MAM-MD-5119) 販売に関する免責事項

[局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021）] ( Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021 / MAM-MD-5119) についてEメールでお問い合わせ

◆関連調査資料◆

薬物送達技術の世界市場予測（～2021）：投与経路別（経口（固体）、経肺（噴霧器）、注射（装置）、経眼（液体）、局所（固体）、移植（活性）、経粘膜（経口））、患者ケア場所別
MAM-MD-3871 / MarketsandMarkets / 2017年1月12日 / 当調査レポートでは、薬物送達技術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、投与経路別分析、患者ケア場所別分析、地域別分析、薬物送達技術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market. Furthermore, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market. The...

新型出生前診断（NIPT）の世界市場予測（～2021）
MAM-BT-5140 / MarketsandMarkets / 2017年3月31日 / 当調査レポートでは、新型出生前診断（NIPT）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、NIPT装置別分析、消耗品別分析、用途別分析、需要先別分析、新型出生前診断（NIPT）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period. The...

Ｉn situハイブリダイゼーション（ISH）の世界市場予測（～2021）：技術別（FISH、CISH）、用途別、需要先別
MAM-BT-3649 / MarketsandMarkets / 2017年1月18日 / 当調査レポートでは、Ｉn situハイブリダイゼーション（ISH）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別分析、用途別分析、需要先別分析、地域別分析、Ｉn situハイブリダイゼーション（ISH）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The in situ hybridization market is projected to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years. The global in situ hybridization market is segmented on the basis of technique, application, and end user. By technique, the market is categorized into fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). The FISH...

肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場予測（～2021年）
MAM-MD-5021 / MarketsandMarkets / 2017年2月20日 / 当調査レポートでは、肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、デバイス別分析、需要先別分析、地域別分析、肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis is expected to drive the market growth during the forecast period. However, emerging markets and growth in online marketing channel offers opportunities for the market. The pulmonary drug delivery market is segmented based on formulations, canister type,...

戦場管理システム（BMS）の世界市場予測（～2021）
MAM-AS2244 / MarketsandMarkets / 2017年4月4日 / 当調査レポートでは、戦場管理システム（BMS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、システム別分析、構成要素別分析、地域別分析、戦場管理システム（BMS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The battlefield management system (BMS) market is projected to grow from USD 13.25 Billion in 2016 to USD 17.14 Billion by 2021, at a CAGR of 5.28% from 2016 to 2021. Increasing need for enhanced situational awareness and for battlefield management systems (BMS) in special operations is the major factor that is expected to drive the battlefield management system (BMS) market in the coming years. On the basis of platform, the battlefield management system (BMS) market has been segmented into headquarter, vehicle, and soldier. The vehicle segment dominates the battlefield management system (BMS) market, in terms of market size and...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆